Ascorbate increases the 1,25 dihydroxyvitamin D3-Induced monocytic differentiation of HL-60 cells

Calcified Tissue International

Volumn 59, Issue 4, 1996, Pages 277-282

  Quesada, J M ^a   Lopez LLuch, G ^b   Buron, M I ^b   Alcain, F J ^b   Borrego, F ^a   Velde, J P ^c   Blanco, I ^b   Bouillon, R ^d   Navas, P ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c Solvay Pharmaceuticals Inc   (Netherlands)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

1,25 Dihydroxyvitamin D3; Ascorbate; Calcitriol; Cell Differentiation; HL 60; Leukemia

Indexed keywords

ASCORBIC ACID; CALCITRIOL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL;

ASCORBIC ACID; CALCITRIOL; CELL DIFFERENTIATION; DRUG SYNERGISM; HL-60 CELLS; MONOCYTES;

EID: 0029803643     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900123     Document Type: Article

References (44)

1. Reichel H, Koeffler HP, Norman AW (1989) The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980-991
2. Walters MR (1992) Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719-764
3. Dusso AS, Negrea L, Gunawardhana S, Lopez-Hilker S, Finch J, Mori T, Nishii Y, Slatopolsky E, Brown AJ (1991) On the mechanisms for the selective action of vitamin D analogs. Endocrinology 128:1687-1694
4. 3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies. Cancer Res 47:567-572
5. Bouillon R, Okamura WH, Norman AW (1995) Structure-function relationship in the vitamin D endocrine system. Endocr Rev 16:200-257
6. 3 on the differentiation of the human monocytic cell line U-937. Leukemia Res 15:1145-1151
7. Gershoff SN (1993) Vitamin C (ascorbic acid): new roles, new requirements?. Nutr Rev 51:313-326
8. Alcain FJ, Buron MI (1994) Ascorbate on cell growth and differentiation. J Bioenerg Biomembr 26:393-398
9. Leglise MC, Dent GA, Ayscue LH, Ross DW (1988) Leukemic cell maturation. Phenotypic variability and oncogene expression in HL-60 cells: a review. Blood Cells 13:319-337
10. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol 98:391-398
11. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, Suda T (1981) 1α,25-Dihydroxycholecalciferol and a human myeloid leukemia cell line (HL-60). Biochem J 204:713-719
12. Yun K, Sugihara H (1986) Cell differentiation and cell cycle effects on human promyelocytic leukemia cells induced by 12-O-tetradecanoylphorbol-13-acetate. Lab Invest 54:336-344
13. Yam LT, Li CY, Crosby WH (1972) Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55: 283-290
14. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-252
15. 3 proling survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 80:201-209
16. 3. Cancer Res 47:21-25
17. 3 modulation of mammary tumor cell growth in vitro and in vivo. Breast Cancer Res Treat 27:69-81
18. 3 and interferon τ in inducing interleukin 1β. Anticancer Res 12:1331-1338
19. 3 and interferon-gamma in inducing interleukin 1β. Anticancer Res 12:1331-1337
20. Yen A, Forbes ME, Varvayanis S, Tykocinski ML, Groger RK, Platko JD (1993) C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression. J Cell Physiol 157:379-391
21. 3-induced terminal monocytic differentiation of human leukemic cell lines. J Immunol 150:2418-2430
22. 3. Leukemia 8:595-604
23. 3 an HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase. Leukemia 7:17-20
24. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB (1990) Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaris cells. J Cell Physiol 143:213-221
25. Franceschi RT (1992) The role of ascorbic acid in mesenchimal differentiation. Nutrition Rev 50:65-70
26. Goralczyk R (1994) L-ascorbic acid is required for vitamin D metabolite-induced osteocalcin secretion in primary rat osteoblasts. In: Norman AW, Bouillon R, Thomasset M (eds). Vitamin D. A pluripotent steroid hormone: structural studies, molecular endocrinology and clinical applications. Walter de Gruyter. Berlin, New York, pp 720-721
27. Turley JM, Sanders BG, Kline K (1992) RRR-α-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60 leukemia) cell proliferation and differentiation. Nutr Cancer 18:201-213
28. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyer SM (1988) The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidyl inositol linkeage. J Immunol 141:547-555
29. Bram S, Froussard P, Guichard M, Jasmin C, Augery Y Sinoussi-Barre F, Wray W (1980) Vitamin C preferential toxicity for malignant melanoma cells. Nature 284:629-631
30. Bishum N, Basu T, Metcalfe S, Williams D (1978) The effect of ascorbic acid (vitamin C) on two tumor cell lines in culture. Oncology 35:160-162
31. Liotti FS, Bodo M, Menghini AR, Guerreri P, Pezzetti F (1986) Antagonism between catalase and ascorbic acid in control of normal and neoplastic cell multiplication. Cancer Lett 33:99-106
32. Hata R, Seno H (1989) L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissue-like substance by skin fibroblasts. J Cell Physiol 138:8-16
33. Park CH, Kimler BF (1991) Growth modulation of human leukemic, preleukemic, and myeloma progenitor cell by L-ascorbic acid. Am J Clin Nutr 54:1241S-1246S
34. Navarro F, Rodriguez-Aguilera JC, Alcain FJ, Buron MJ, Navas P (1992) Ascorbate potentiates serum-induced S phase entry of quiescent 3T3 cells. Protoplasma 169:85-87
35. Alcain FJ, Buron MI, Rodriguez-Aguilera JC, Villalba JM, Navas P (1990) Ascorbate free-radical stimulated growth of a human promyelocytic leukemia cell line. Cancer Res 50: 5887-5891
36. Tsao CS, Dunham WB, Leung PY (1992) Effect of ascorbic acid and its derivatives on the growth of human mammary xenografts in mice. Cancer J 5:53-59
37. 3 and 3′,5′-cyclic adenosine monophosphate in rat osteosarcoma cells. Mol Endocrinol 3:36-43
38. De Cremoux P, Calvo F, Cost H, Gauville C, Lagier G, Abita JP, Lechat P (1987) 1,25-dihydroxycholecalciferol induces an increase in PGE1 and forskolin-stimulated cyclic AMP production in T47D human breast cancer cell line. Fundam Clin Pharmacol 1:347-354
39. 3 in cardiac muscle. Mol Cell Endocrinol 82:229-235
40. 3, α-melanocyte stimulating hormone, and beta-estradiol. J Invest Dermatol 91:593-599
41. 3 on HL-60 cells. Cancer Res 49:72-75
42. Navas P, Villalba JM, Cordoba F (1994) Ascorbate function at the plasma membrane. Biochim Biophys Acta 1197:1-13
43. Bang BE, Ericsen C, Aarbakke J (1994) Effects of cAMP and cGMP elevating agents on HL-60 cell differentiation. Pharmacol Toxicol 75:108-112
44. Jung EY, Ohshima Y, Shintaku N, Yumimoto SI, Haike T, Katamura K, Mayumi M (1994) Effects of cyclic AMP on expression of LFA-1, Mac-1 and VLA-4 and eosinophilic differentiation of a human leukemia cell line, EoL-1. Eur J Haematol 53:156-162